beximco presentation from salehin

7/31/2019 Beximco Presentation from Salehin

1/19

Beximco Pharmaceutical

Ltd.


2/19

Submitted by:

Noor Ibne Salehin 111082071

Department of Business Studies

United International University


3/19

Introduction

Beximco Pharmaceutical Ltd is themanufacturer and marketer ofpharmaceutical product under chemicaldivisions of Beximco Group. Beximco

Pharmaceuticals is one of the leadingpharmaceutical companies in Bangladesh.It also is one of the biggest suppliers ofpharmaceutical product of anyBangladeshi based company. BPL is the

first Bangladeshi company to supplypharmaceutical product to Riffles Hospitalthe most prestigious hospital of Singapore.


4/19

History

Beximco was the first private sectorcompany to be registered in Bangladeshas a public limited company in September1972. Since then, Beximco has taken the

lead in public equity offerings inBangladesh. At the end of 1996, the tenpublicly listed companies of the BeximcoGroup accounted for Tk. 33.87 billion or20.4% of the market capitalization of the

Dhaka stock exchange and Tk. 31.12billion or 21.3% of the marketcapitalization in Chittagong stockexchange.


5/19

Quick view of BPL

Official Name - BEXIMCOPharmaceuticals Ltd (BPL)

Type - Public Limited Company Founded - 1980 Headquarters - Dhaka, Bangladesh

Key people - Nazmul Hassan (CEO) Industry - Pharmaceutical Slogan - We are bulding a healther

tomorrow Logo - Business Information - The company's annual

production exceeds $50 million. It employs over 1900 Source : web page
http://en.wikipedia.org/wiki/1980http://en.wikipedia.org/wiki/Dhakahttp://en.wikipedia.org/wiki/Bangladeshhttp://en.wikipedia.org/wiki/Industryhttp://en.wikipedia.org/wiki/Industryhttp://en.wikipedia.org/wiki/Pharmaceuticalhttp://en.wikipedia.org/wiki/Pharmaceuticalhttp://en.wikipedia.org/wiki/Industryhttp://en.wikipedia.org/wiki/Industryhttp://en.wikipedia.org/wiki/Bangladeshhttp://en.wikipedia.org/wiki/Dhakahttp://en.wikipedia.org/wiki/1980


6/19

Vision

Our vision building a healthier tomorrowwhere our fellow citizens will live longer,healthier and happier. Our activities

have always been centered nondeveloped core competences to deliverthe best in the industry ensuringsuperior value and return to our

costumers.


7/19

Mission

Each of the activities must benefitand add value to the commonwealth of the society We firmly

believe that in the final analysis weare accountable to each of theconstituents with whom we interactnamely our employees our

customers, our business associates,our fellow citizens andshareholders..


8/19

Sister Concern of BPL

There are four sub division of BPL, Those are following:

>Beximco pharmaceuticals Ltd.>Pharma Tek

>Beximco Chemical

>I & I Service Ltd.

Pharmaceuticals Ltd

Beximco Chemical

Pharma Tek I & I Service


9/19


10/19

Success Area of BPL

Until now I have tried to explain the performance ofBeximco pharmaceuticals Ltd in the overall market and alsoin different area of country and abroad. But let us try toanalyze the reason for which Beximco Pharmaceuticals isone of leading Brand in country. From my point of view Ithink the following variables plays the most important partbehind the success of Beximco Pharmaceuticals Ltd. inBangladesh and also across the globe. They are-

New Technology

New Innovation.

Nation Wide Distribution Strength.

New People Experienced Work.


11/19

New Technology :

Quality is the ultimate factor that works in themind of the customers which create brand imageat the end of day. The Beximco PharmaceuticalsLtd. is known for its products. The strength ofBPL lies in its quality controls system and up to

date manufacturing facilities. It has establishedmanufacturing facilities conforming to GMP andWHO standards. During all stages ofmanufacturing operation from receiving rawmaterial to the release of the finished product the

requirement of GMP are strictly adopted.


12/19

New Innovation:

Product innovation is successive factor behind thesuccess of Beximco Pharmaceuticals Ltd in thepharmaceutical industry of Bangladesh. BPLknew that in order to survive in this challengingmarket product innovation is need to focus on

deeply. So, as result research and developmentdepartment were established in order to innovatenew product, improving production process,product quality for further strengthen the positionof BPL in the industry. This R & D teams is also

continuously monitoring market feedback ofvarious product to find ways of betterment. In2005 BPL adds 49 new products lunched across arange of therapeutic classes with its existingbrands including dosage forms and strength.


13/19

Nation Wide Distribution

Strength: Distribution of product is very important no matter how

good product is. In case Beximco pharmaceuticals Ltd. thedistribution of BPL product is really good. In fact BPL has adistribution unit I & I services Ltd which is the distributionwing of chemical divisions. It maintained a largedistribution network and covers over 25000 retail

pharmacies every month all over the country. Along withthis a highly sophisticated computerized order processingsystem, adequate logistic facilities like vehicles, depots andalso professional sales people are also there in order tokeep pace with increasing market demand. So, strongdistribution system of BPL plays a vital role in the successof BPL in Pharmaceutical industry Bangladesh.


14/19

New People Experienced Work :

BPL is adopting all modern technology which strengthen thequality of product in more efficient manner. From my pointview I think this is another reason for the success of BPL inBangladesh and also across the globe. BPLs most vitalresource is its people. Its dedicated team of professionalsform various disciplines are integrated in conducive

environment to achieve companies objective. The people ofBPL strongly believe in the companys philosophy of servingthe nation and contributing to the society. BPLs over 1,981young, energetic, professionals ensures the timelypromotion and smooth running of the product to everyparts of the country. Thus this is another factor for thesuccess of BPL.


15/19

Products of BPL

Arbit Cox B

Apresin Curin

Arixon Deflux

Azmasol Diapro

Bextrum Ecotrim

Betapro Napa

Burnsil Omnivit

Cesonide Neoceptin R


16/19

Share Condition

Last Trade Price: 181.70 Yesterday Close Price: 183.80 Change Amount: -2.1

Change (in Percentage): -1.14% Opening Price:184.50 High Price: 184.50 Low Price: 181.10

Total Trade: 4514

Source: DSE: April 5,2010


17/19

Achievement of BPL

With a record of highest growth rate in thehistory of Bangladesh Pharmaceuticalindustry, BPL has maintained itsleadership position with consistent growth

over the year. The company maintainedits growth performance in 1999 evenwhen the industry experienced a decline inmarket growth during the same period oftime. It is continuously adding new

products of different therapeutic classes inits portfolio and those products are alwaysappreciated by the health professionals.


18/19


19/19

Conclusion

Pharmaceutical sector is one of the fast growingand most developed scientific sector inBangladesh. There are about 250 registeredpharmaceutical companies operating inBangladesh pharmaceutical industry. The market

is highly competitive. It is really difficult to getresponse from the market. Here the targetcustomer is different type of specialist doctors.Company depends on those physiciansprescription, because doctors are prescribing

some medicines and accordingly patients followsthe doctors instruction. Sometime chemistsshops also influence the patients to take medicineas their choice. So, the pharmaceuticalcompanies have to know about their targetcustomers behavior and market condition to

develop marketing strategies based on thissituation

beximco presentation from salehin

Documents